James Robert Dennewill Jr. - 05 Feb 2026 Form 3 Insider Report for SpyGlass Pharma, Inc. (SGP)

Signature
/s/ Brian Aukshunas, as Attorney-in-Fact
Issuer symbol
SGP
Transactions as of
05 Feb 2026
Net transactions value
$0
Form type
3
Filing time
05 Feb 2026, 13:04:06 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dennewill James Robert Jr. Chief Operating Officer C/O SPYGLASS PHARMA, INC., 27061 ALISO CREEK RD., SUITE 100, ALISO VIEJO /s/ Brian Aukshunas, as Attorney-in-Fact 05 Feb 2026 0002106895

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SGP Common Stock 96,022 05 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGP Stock Option (right to buy) 05 Feb 2026 Common Stock 78,494 $2.18 Direct F1
holding SGP Stock Option (right to buy) 05 Feb 2026 Common Stock 35,758 $2.87 Direct F2
holding SGP Stock Option (right to buy) 05 Feb 2026 Common Stock 54,745 $7.11 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean October 6, 2023.
F2 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 20, 2025.
F3 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 30, 2025.

Remarks:

Exhibit 24 - Power of Attorney